NCT04436588View on ClinicalTrials.gov

Better Delineation of DDX3X Related Phenotype and Epigenetic Signature.

UnknownOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

December 1, 2020

Study Completion Date

December 1, 2020

Conditions
Intellectual Developmental DisorderX-LINKED
Interventions
GENETIC

Epigenetic signatures

Epigenetic signatures (Dr Sadikovic' lab, London, Ontario, Canada)

Trial Locations (1)

34295

UH Montpellier, Montpellier

Sponsors

Collaborators (1)

Genida
All Listed Sponsors
collaborator

Association Xtraordinaire sub-group DDX3X

UNKNOWN

collaborator

Genida

UNKNOWN

lead

University Hospital, Montpellier

OTHER